Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.
COVID-19
SARS-CoV-2
genetic variants
high-throughput sequencing
spike protein
syncytia
Journal
mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231
Informations de publication
Date de publication:
29 06 2021
29 06 2021
Historique:
pubmed:
30
6
2021
medline:
23
7
2021
entrez:
29
6
2021
Statut:
ppublish
Résumé
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus that is continuously evolving. Although its RNA-dependent RNA polymerase exhibits some exonuclease proofreading activity, viral sequence diversity can be produced by replication errors and host factors. A diversity of genetic variants can be observed in the intrahost viral population structure of infected individuals. Most mutations will follow a neutral molecular evolution and will not make significant contributions to variations within and between infected hosts. Herein, we profiled the intrasample genetic diversity of SARS-CoV-2 variants, also known as quasispecies, using high-throughput sequencing data sets from 15,289 infected individuals and infected cell lines. Despite high mutational background, we identified recurrent intragenetic variable positions in the samples analyzed, including several positions at the end of the gene encoding the viral spike (S) protein. Strikingly, we observed a high frequency of C→A missense mutations resulting in the S protein lacking the last 20 amino acids (SΔ20). We found that this truncated S protein undergoes increased processing and increased syncytium formation, presumably due to escaping M protein retention in intracellular compartments. Our findings suggest the emergence of a high-frequency viral sublineage that is not horizontally transmitted but potentially involved in intrahost disease cytopathic effects.
Identifiants
pubmed: 34182784
doi: 10.1128/mBio.00788-21
pmc: PMC8262852
doi:
Substances chimiques
Spike Glycoprotein, Coronavirus
0
spike protein, SARS-CoV-2
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0078821Subventions
Organisme : Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)
ID : OV1 170355
Organisme : Gouvernement du Canada | Canadian Institutes of Health Research (CIHR)
ID : OV3 170632
Références
J Biol Chem. 1992 Jan 5;267(1):166-72
pubmed: 1730583
Bioinformatics. 2017 Nov 15;33(22):3645-3647
pubmed: 29036507
Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13910-3
pubmed: 10570172
Nat Struct Mol Biol. 2011 Feb;18(2):230-6
pubmed: 21258325
J Virol. 2007 Mar;81(5):2418-28
pubmed: 17166901
J Biol Chem. 2020 Sep 11;295(37):12910-12934
pubmed: 32661197
PeerJ. 2020 May 21;8:e9255
pubmed: 32509472
Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):8194-9
pubmed: 27382162
Annu Rev Microbiol. 1988;42:489-516
pubmed: 3144239
Genes (Basel). 2018 Dec 27;10(1):
pubmed: 30591678
Osong Public Health Res Perspect. 2020 Jun;11(3):101-111
pubmed: 32528815
N Engl J Med. 2020 Jun 11;382(24):2302-2315
pubmed: 32289214
PLoS Genet. 2019 Oct 17;15(10):e1008271
pubmed: 31622336
JMIR Public Health Surveill. 2020 Jun 1;6(2):e19170
pubmed: 32412415
Infect Genet Evol. 2020 Sep;83:104351
pubmed: 32387564
Infect Genet Evol. 2020 Jul;81:104260
pubmed: 32092483
EBioMedicine. 2020 Nov;61:103104
pubmed: 33158808
Cell Host Microbe. 2020 Sep 9;28(3):486-496.e6
pubmed: 32738193
J Virol. 2004 Jun;78(11):5913-22
pubmed: 15140989
J Exp Med. 2020 Nov 2;217(11):
pubmed: 32692348
Nucleic Acids Res. 2002 Mar 15;30(6):1354-63
pubmed: 11884633
Mol Cell. 2020 May 21;78(4):779-784.e5
pubmed: 32362314
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
RNA Biol. 2011 Mar-Apr;8(2):270-9
pubmed: 21593585
Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9530-5
pubmed: 21586637
Nat Rev Microbiol. 2021 Mar;19(3):155-170
pubmed: 33116300
J Virol. 2009 Nov;83(22):11447-55
pubmed: 19726505
DNA Res. 2016 Dec;23(6):547-559
pubmed: 27477585
Nat Biotechnol. 2019 Aug;37(8):907-915
pubmed: 31375807
Nucleic Acids Res. 2013 Apr 1;41(6):e67
pubmed: 23303777
mSphere. 2020 Jun 24;5(3):
pubmed: 32581081
Cell Host Microbe. 2020 Sep 9;28(3):475-485.e5
pubmed: 32735849
J Virol. 2010 Dec;84(24):12658-64
pubmed: 20926566
Science. 2017 Feb 17;355(6326):752-756
pubmed: 28209900
Bioinformatics. 2011 Nov 1;27(21):2987-93
pubmed: 21903627
Cells. 2020 May 20;9(5):
pubmed: 32443810
J Biol Chem. 2021 Jan-Jun;296:100111
pubmed: 33229438
Nat Rev Microbiol. 2021 Mar;19(3):141-154
pubmed: 33024307
Emerg Microbes Infect. 2020 Dec;9(1):1393-1396
pubmed: 32552549
Nat Commun. 2020 Mar 27;11(1):1620
pubmed: 32221306
Int J Mol Sci. 2020 Dec 17;21(24):
pubmed: 33348900
Cell. 2020 May 28;181(5):1036-1045.e9
pubmed: 32416070
Gene. 2020 Aug 20;752:144792
pubmed: 32445924
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
J Virol. 2010 Oct;84(19):9733-48
pubmed: 20660197
Nat Rev Microbiol. 2015 Aug;13(8):484-96
pubmed: 26119571
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Int J Hyperthermia. 2014 Nov;30(7):513-23
pubmed: 25354680
PLoS One. 2013 Oct 03;8(10):e76469
pubmed: 24098509
Methods Mol Biol. 2015;1282:1-23
pubmed: 25720466
J Virol. 2019 May 15;93(11):
pubmed: 30867314
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Int J Mol Sci. 2019 Jan 08;20(1):
pubmed: 30625989
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3578-82
pubmed: 9520408
EMBO J. 2020 Dec 1;39(23):e106267
pubmed: 33051876
Sci Adv. 2020 Jun 17;6(25):eabb5813
pubmed: 32596474